Skip to main content
Videos

Ten-Year Survival Data of Dabrafenib Plus Trametinib for Patients With Stage III BRAF V600E/K Melanoma After Surgery


This sponsored video presents the 10-year survival data of dabrafenib plus trametinib for patients with stage II BRAF V600E/K melanoma after surgery.

This is a sponsored video. The opinions and recommendations expressed in this video do not necessarily reflect the views of Oncology Learning Network or HMP Global. This program is not intended or eligible for continuing education credits and does not meet guidelines governing CME/CE.